Life sciences software & AI news

Showing 1000+ results

Oct 15, 2026

Nabla Integrates with OpenEvidence to Deliver Clinical Evidence at the Point of Care

New integration brings clinical decision support into the encounter workflow, connecting patient context with evidence-based guidance to help clinicians make informed decisionsNEW YORK, Oct. 15, 2026 /PRNewswire/ -- Nabla, one of the most widely adopted AI assistants in clinical care, today announced an integration with OpenEvidence, the leading AI-powered clinical decision support platform, making trusted medical evidence accessible within Nabla.Continue Reading Clinical docume

Oct 15, 2026

Press release

insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and Cardiomyopathies

Collaboration applies insitro's Virtual Human causal AI discovery platform to two diseases defined by patient heterogeneity and high unmet medical needinsitro to receive $40 million upfront and up to approximately $1.46 billion in potential discovery, development, and commercial milestones, and tiered royaltiesSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, an AI company unlocking causal human biology to systematically generate high-value therapeutics to treat grievous illness, today anno

Oct 15, 2026

Press release

NHS Announces £838m GP IT Framework

15 October 2026 DXS INTERNATIONAL PLC (AQSE: DXSP) NHS Announces £838m GP IT Framework DXS International plc (AQSE: DXSP), the UK healthcare technology provider, welcomes the announcement from NHS England which has announced plans for a new £838.7m open framework for GP IT solutions, marking a significant step towards revitalising procurement across UK general practice. The new framework is intended to replace GP IT Futures, which expired in March 2023 and whose subsequent procurement constrai

Oct 15, 2026

Press release

BIOMEMORY LAUNCHES DNA SHIELD, THE FIRST COMMERCIAL PRODUCT BUILT ON ITS MOLECULAR IT PLATFORM

Following the acquisition of Catalog's assets and the appointment of Laurent Guengant as CEO earlier this year, Biomemory opened Early Access to DNA shield, its first commercial product for sovereign data protection, establishing the company as an early leader in molecular IT.PARIS and BOSTON , Oct. 15, 2026 /PRNewswire/ -- Biomemory, a leader in commercial DNA data storage and co-chair of the DNA Data Storage Alliance, today announced the launch of DNA Shield, a managed service for sovereign da

Oct 15, 2026

Press release

wisepatientAI Turns Your Medical Records Into Answers You Can Understand

New AI capability lets patients ask questions about their own medical history in everyday language and receive answers based on their records.ALBUQUERQUE, N.M., Oct. 15, 2026 /PRNewswire/ -- wisepatientAI today announced the launch of AI-powered search, allowing patients to ask questions about their own medical records in everyday language and receive answers based on those records. By simply downloading records from one provider, patients can use wisepatient's powerful AI to learn more about th

Oct 15, 2026

Press release

DaltonTx awarded grant to accelerate AI-powered tuberculosis drug discovery

Funding from the Gates Foundation supports development of open-access AI models, workflows and datasets to help researchers identify new tuberculosis (TB) targets for faster and more cost-effective drug discoveryProject will analyse hundreds of essential TB proteins at proteome scale, demonstrating Dalton’s ability to tackle complex scientific challenges Collaboration with Ersilia will make findings accessible to researchers across the Global South LONDON, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Da

Oct 15, 2026

Press release

Elsevier Commits to Accelerate AI-Driven Science Across Europe

Commitment to the European Commission's AI in Science Enablers Initiative includes 4,000 complimentary AI product licenses, support for new research collaborations, and expanded PhD, postdoctoral, and master's training in AI-assisted researchDUBLIN, Oct. 15, 2026 /PRNewswire/ -- Elsevier, a global leader in advanced information and decision support in science and healthcare, today announced its pledge to the European Commission's AI in Science Enablers Initiative.Elsevier's contribution spans co

A flat illustration of a hard drive and data cable representing health data access.

Oct 15, 2026

From Hard Drives to Self-Service: How ASU and Starfish Storage Unlocked 25 Years of Indigenous Health Data

Arizona State University (ASU) and Starfish Storage have revolutionized access to health data from the Tsimane Health and Life History Project, significantly reducing the time researchers spend retrieving critical information.For over 25 years, researchers studying the Tsimane, an indigenous Bolivian community known for their exceptional health and longevity, faced considerable delays in accessing vital imaging data. Previously, the process involved manually transferring data via hard drives, wh

Oct 15, 2026

Press release

Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications

Now free on the App Store and Google Play, Qare matches users into cohorts by medication and demographic profile, generating a database of user-reported real-world experience data that Lōkahi believes may become a source of long-term value to patients and manufacturers RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced the public launch of Qare™, a comparative health platform designed to help users comp

Oct 15, 2026

Press release

New York City Biotech Startups Neion Bio and Barnwell Bio Partner to Advance Biomanufacturing and Biosecurity

The collaboration brings together Neion Bio's egg-based biologics manufacturing platform and Barnwell Bio's metagenomic biosurveillance capabilities, while highlighting the growing New York City life sciences ecosystemBarnwell Bio FoundersThe EggNeion Bio FoundersNEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, and Barnwell Bio, an animal health intelligence company, today announced a strategic collaboration und

Minimalist illustration of a breast and MRI scan silhouette

Oct 15, 2026

SimBioSys nabs FDA clearance for Nvidia-powered, MRI-derived breast cancer recurrence tool

SimBioSys has received FDA clearance for TumorSight Risk, an innovative AI-based tool designed to assess the risk of breast cancer recurrence using MRI data.This platform leverages routine breast MRI, pathology, and clinical data to generate personalized prognoses for patients at five and ten years. It specifically aids oncologists in treatment planning for hormone receptor-positive (HR+), HER2-negative Stage I–IIIA breast cancer, which constitutes approximately 75% of breast cancer cases in the

Oct 15, 2026

Press release

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced the publication of its study "Diagnostic Yield of Genome Sequencing for Children with Intellectual Disability and Developmental Delay (ID/DD)” in Frontiers in Neurology. This study assessed the ability of Baylor Genetics’ Whole Genome Sequencing (WGS) test to identify diagnoses for pediatric patients wi

Back to start
Previous
Page 42 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Domains

Services

Legal